Recommendations for the reporting of prostate carcinoma

Human Pathology

Volumn 38, Issue 9, 2007, Pages 1305-1309.e4

  Epstein, Jonathan I ^a   Srigley, John ^b   Grignon, David ^c   Humphrey, Peter ^d  

^a DEPARTMENT OF PATHOLOGY   (United States)

^b CREDIT VALLEY HOSPITAL   (Canada)

^c INDIANA UNIVERSITY   (United States)

^d WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

ADASP; Practice Guidelines; Prostate Practice Guidelines

Indexed keywords

ARTICLE; CANCER DIAGNOSIS; CANCER GRADING; CANCER INVASION; CANCER REGISTRY; CANCER STAGING; CANCER SURGERY; CLINICAL PROTOCOL; HISTOLOGY; HUMAN; NEEDLE BIOPSY; PRACTICE GUIDELINE; PROGNOSIS; PROSTATE CARCINOMA; PROSTATECTOMY; PROSTATIC INTRAEPITHELIAL NEOPLASIA; QUESTIONNAIRE; STANDARDIZATION; TREATMENT OUTCOME;

EID: 34547828810     PISSN: 00468177     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.humpath.2007.05.015     Document Type: Article

References (14)

1. Amin M., Boccon-Gibod L., Egevad L., et al. Prognostic and predictive factors and reporting of prostate carcinoma in prostate needle biopsy specimens. (2004 WHO-sponsored International Consultation Consensus). Scand J Urol Nephrol 39 Suppl 216 (2004) 20-33
2. In: Eble J.N., Sauter G., Epstein J.I., and Sesterhenn I.A. (Eds). Pathology and genetics of tumours of the urinary system and male genital organs (2004), Lyon: IARC Press PB 162-PB 192
3. Epstein J.I. The evaluation of radical prostatectomy specimens: therapeutic and prognostic implications. Pathol Annu 26 (1991) 159-210
4. Epstein J.I., Amin M., Boccon-Gibod L., et al. Prognostic factors and reporting of prostate carcinoma in radical prostatectomy and pelvic lymphadenectomy specimens. (2004 WHO-sponsored International Consultation Consensus). Scand J Urol Nephrol 39 Suppl 216 (2004) 34-63
5. Grignon D.J., and Sakr W.A. Pathologic staging of prostate carcinoma: what are the issues?. Cancer 78 (1996) 337-340
6. May F., Hartung R., and Breul J. The ability of the American Joint Committee on Cancer Staging system to predict progression-free survival after radical prostatectomy. BJU Int 88 (2001) 702-777
7. Ohori M., Kattan M., Scardino P.T., and Wheeler T.M. Radical prostatectomy for carcinoma of the prostate. Mod Pathol 17 (2004) 349-359
8. Young R.H., Srigley J.R., Amin M.B., Ulbright T.M., and Cubilla A. Tumors of the prostate gland, seminal vesicle, male urethra and penis. In: Rosai J. (Ed). Atlas of Tumor Pathology. Series 3 (2000), Armed Forces Institute of Pathology, Washington (DC)
9. Epstein J.I., Allsbrook W.C., Amin M.B., and Egevad L.L. The 2005 International Society of Urological Pathology (ISUP) consensus conference on Gleason grading of prostatic carcinoma. Am J Surg Pathol 29 (2005) 1228-1242
10. Gleason D.R., Mellinger G.T., and The Veterans Administration Cooperative Urological Research Group. Prediction of prognosis for prostate adenocarcinoma by combined histological grading and clinical staging. J Urol 111 (1974) 58-64
11. Epstein J.I., and Herawi M. Prostate needle biopsies containing prostatic intraepithelial neoplasia or atypical foci suspicious for carcinoma: implications for patient care. J Urol 175 (2006) 820-834
12. Eichelberger L.E., and Cheng L. Does pT2b prostate cancer exist? Critical appraisal of the 2002 TNM classification of prostate cancer. Cancer. 100 (2004) 2573-2576
13. Freedland S.J., Partin A.W., Epstein J.I., and Walsh P.C. Biochemical failure after radical prostatectomy in men with pathologic organ-confined prostate cancer: pT2 versus pT2b. Cancer 100 (2004) 1646-1649
14. Humphrey P.A., and Walther P.J. Adenocarcinoma of the prostate, I: simple sampling considerations. Am J Clin Pathol 99 (1993) 746-759